|
OVID Ovid Therapeutics Inc 1636651 |
| Balance Sheet |
|
Current Assets
|
$123,617,000.00 |
|
Assets
|
$231,973,000.00 |
|
Current Liabilities
|
$9,980,000.00 |
|
Liabilities
|
$22,083,000.00 |
|
Equity
|
$209,890,000.00 |
|
Shares Out
|
184755735.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-31,493,000.00 |
|
Investing Cash Flow
|
$-80,790,000.00 |
| Market Analysis |
Market Cap
|
$506,230,713.90 |
|
Price
|
$2.74 |
|
BVPS
|
1.14 |
|
PB
|
2.40 |
|
EPS
|
-0.20 |
|
PS
|
172.66 |
|
FCF
|
$-31,493,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:40 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:31 |
|
| Apr |
May |
Jun |
| 2026-03-18 |
0.06 |
|
|
2026-05-12 |
-0.12 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-0.06 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.17 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view OVID documents filed with the SEC.
OVID Filings
Clear
